Australia's most trusted
source of pharma news
Thursday, 7 May 2026
Thursday, 7 May 2026
Subscribe
Login
Industry's 'Most Influential' named
A lone Big Pharma has made it onto this year's prestigious TIME100 list, hailed for a first-to-market win that has made their drug more convenient and more accessible to patients.
Sweet upside for obesity drugs
Bracing for fallout from booming GLP-1 uptake, chocolate manufacturers have instead been delivered a surprise windfall
TODAY
$135M market under threat
Exclusivity of four drugs is at risk after a judge allowed the patent term extension protecting them to be challenged
TODAY
Aussie class action targets pharma
Law firm continues to assess a "significant number" of enquiries and registrations from people who have used these drugs
6 May
Lilly GM confirms drug launch
Newly approved treatment soon to roll out on private script with Aussie boss acknowledging the "significant challenges" in securing subsidy
5 May
What happened to the PBS in Q1?
There was a significant drop in PBS reimbursements during Q1, but the Department couldn't offer a definitive explanation
5 May
Why pharma new hires are quitting
Onboarding at Aussie pharma companies is failing to create emotional attachment to work driving new hires to quit
4 May
Latest Jobs
Surgical Sales SpecialistSurgical Sales SpecialistPharmacy AssistantSenior Recruitment ConsultantRegional Quality HeadWarehouse AssistantCustomer Service Team LeaderRegulatory Submissions Specialist24 more...
Pharma in Focus Jobs
Marketing & Communications (8)
- Trade Marketing Manager - Sydney
- Product Manager - New South Wales
- Internal Communications Specialist - Melbourne
- Trade Marketing Manager - Sydney
- Senior Product Manager - Sydney
- Associate Marketing Manager - OTC - Sydney
- Senior Data & Insights Analyst - Melbourne
- Data & Insights Analyst - Melbourne
Sales & Customer Relations (8)
- Surgical Sales Specialist - Auckland
- Surgical Sales Specialist - Auckland
- Customer Service Team Leader - Frenchs Forest
- Territory Manager - Melbourne
- Territory Manager - Surgical - Sydney
- Pharmaceutical Sales Representative - Sydney
- Account Manager - Sydney
- Senior Territory Manager - Melbourne
Clinical & Medical, R&D (4)
- Senior Medical Manager - Melbourne
- Senior Medical Science Liaison - Melbourne
- Clinical Trial Start Up Specialist - Melbourne
- Clinical Project Manager - Oncology - Sydney, NSW
Regulatory, Pharmacovigilance & QA (4)
- Regional Quality Head - Sydney
- Regulatory Submissions Specialist - Melbourne
- Senior Regulatory Affairs Associate - Sydney
- QA Specialist - Melbourne
Other (9)
Troubled drug faces new drama
After 8 deaths the FDA is now investigating whether data for a major drug was manipulated, and the TGA is paying attention
TODAY
Industry's global jobs purge ongoing
While Australia is in the clear, the one-time darling of the pandemic plus two other companies trim their OS workforces
TODAY
Who's hit a 25-year milestone?
An idea jotted on the back of a cafe napkin plus a healthy dose of ambition, has seen this company grow into a great Aussie success story
6 May
Bridge Program spans a decade
Collaboration between Australian pharma companies, universities and industry affiliates has celebrated its 10th year
6 May
Look who's opening a US office
With growing demand from global pharma for its AI commercialisation platform, this Aussie company is setting up in Boston
6 May
Board wipeout hits local company
In less than a month an activist investor has won the resignation of a CEO and changed the entire board of this company
6 May
Finally... CAR T funded after five years
Fourth CAR T-cell therapy funded in Australia - and the first for multiple myeloma - marking almost 1200 days since it was first submitted
5 May
Sandoz wins consensus on biosims
Stakeholders are united on what needs to be done to increase the uptake of biosims starting with helping the patient hip pocket
5 May
PBS increase to strain Budget
Govt foreshadows that increased spending on subsidising pharmaceuticals will be the third greatest pressure on the Budget
5 May
Who's made a move to new digs?
While marking a milestone in Australia, this pharma is focused on the future with a long-term commitment to collaboration and innovation
4 May
Aussie discovery goes commercial
First-in-class drug developed from local research has been TGA approved, with the sponsor "exploring" PBS reimbursement
4 May
Blast from the past heads to PBAC
A treatment deferred four years ago is back on the agenda, along with a cancer drug that was marked 'ceased' at the start of April
4 May
siRNA specialist enters Aust market
TGA approves first-in-class siRNA therapeutic, a new brand of Eisai's kinase inhibitor, plus a long list of generics of PBS listed drugs
4 May Approvals Action
Who's won an MA Board seat?
After 10 Country Leaders put up their hand to join the Board of industry peak body, these four made the cut
1 May